HSV-1 gC Antibodies

Santa Cruz Biotechnology offers a broad range of HSV-1 gC monoclonal antibodies for research focused on understanding glycoprotein C in herpes simplex virus type 1. HSV-1 gC monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein C (gC) serves as a crucial component of the HSV-1 envelope, playing a significant role in viral entry and immune evasion. Through binding to complement component C3b, glycoprotein C enables the virus to evade host immune responses, facilitating infection and persistence. Research into HSV-1 glycoprotein C functions continues to reveal important aspects of viral mechanisms and potential therapeutic targets. Understanding glycoprotein C behavior and interactions provides valuable insights for developing new treatment approaches. Investigating HSV-1 glycoprotein C has led to significant discoveries about viral entry mechanisms and immune system interactions. Current research utilizing HSV-1 gC monoclonal antibodies focuses on identifying novel therapeutic strategies and understanding viral pathogenesis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of herpes simplex virus and developing innovative therapeutic solutions.